AU5870090A - Topical formulations - Google Patents

Topical formulations

Info

Publication number
AU5870090A
AU5870090A AU58700/90A AU5870090A AU5870090A AU 5870090 A AU5870090 A AU 5870090A AU 58700/90 A AU58700/90 A AU 58700/90A AU 5870090 A AU5870090 A AU 5870090A AU 5870090 A AU5870090 A AU 5870090A
Authority
AU
Australia
Prior art keywords
topical formulations
topical
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU58700/90A
Other versions
AU638034B2 (en
Inventor
Pier Giorgio Ferrini
Jonathan Green
Peter Heinrich Stahl
Carlo Voellmy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Henkel AG and Co KGaA
Original Assignee
Ciba Geigy AG
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Henkel AG and Co KGaA filed Critical Ciba Geigy AG
Publication of AU5870090A publication Critical patent/AU5870090A/en
Application granted granted Critical
Publication of AU638034B2 publication Critical patent/AU638034B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU58700/90A 1989-07-07 1990-07-04 Topical formulations Ceased AU638034B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2795/89 1989-07-07
CH279589 1989-07-07

Publications (2)

Publication Number Publication Date
AU5870090A true AU5870090A (en) 1991-01-10
AU638034B2 AU638034B2 (en) 1993-06-17

Family

ID=4241754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58700/90A Ceased AU638034B2 (en) 1989-07-07 1990-07-04 Topical formulations

Country Status (13)

Country Link
EP (1) EP0407345A3 (en)
JP (1) JPH0344396A (en)
KR (1) KR910002451A (en)
AU (1) AU638034B2 (en)
CA (1) CA2020563A1 (en)
DD (1) DD300353A5 (en)
FI (1) FI903328A0 (en)
HU (1) HU206267B (en)
IE (1) IE902482A1 (en)
MX (1) MX21453A (en)
NZ (1) NZ234378A (en)
PT (1) PT94610A (en)
ZA (1) ZA905310B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
PE20011061A1 (en) 2000-02-01 2001-11-20 Procter & Gamble SELECTIVE CRYSTALLIZATION OF 3-PYRIDYL-1-HYDROXY-ETHYLIDEN-1,1-BISPHOSPHONIC SODIUM ACID AS HEMIPENTAHYDRATE OR MONOHYDRATE
KR100732454B1 (en) * 2001-08-31 2007-06-27 재단법인 포항산업과학연구원 Device for high temperature X-ray experiments
EP1923049A1 (en) * 2006-11-17 2008-05-21 Besins Healthcare Pharmaceutical compositions comprising a bisphosphonate compound
CA2669489A1 (en) * 2006-11-17 2008-05-22 Besins Healthcare Liquid pharmaceutical compositions comprising a bisphosphonate compound
AU2013232576B2 (en) 2012-03-14 2016-09-01 Novan, Inc. Nitric oxide releasing pharmaceutical compositions
CA2920110C (en) 2013-08-08 2022-05-31 Novan, Inc. Compositions and kits including a nitric oxide releasing compound and a hydrogel
CA2919733A1 (en) 2014-08-08 2016-02-08 Novan, Inc. Topical compositions and methods of using the same
KR102319497B1 (en) 2016-03-02 2021-11-01 노반, 인크. Composition for treating inflammation and method for treating inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (en) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Use of 3-amino-1-hydroxypropane-1, 1-diphosphonic acid or its water-soluble salts for influencing calcium metabolic disorders in the human or animal body
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
DE3623397A1 (en) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh NEW DIPHOSPHONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
GB8618259D0 (en) * 1986-07-25 1986-09-03 Leo Pharm Prod Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
HUT54503A (en) 1991-03-28
CA2020563A1 (en) 1991-01-08
DD300353A5 (en) 1992-06-04
ZA905310B (en) 1991-03-27
EP0407345A2 (en) 1991-01-09
AU638034B2 (en) 1993-06-17
KR910002451A (en) 1991-02-25
IE902482A1 (en) 1991-02-13
FI903328A0 (en) 1990-07-02
NZ234378A (en) 1992-08-26
PT94610A (en) 1991-03-20
EP0407345A3 (en) 1991-07-24
HU206267B (en) 1992-10-28
JPH0344396A (en) 1991-02-26
HU904127D0 (en) 1990-12-28
MX21453A (en) 1994-01-31

Similar Documents

Publication Publication Date Title
AU5748990A (en) Venoscope
AU5874690A (en) Octreotide-pamoate
AU627080B2 (en) Sulphonylaminocarbonyltriazolinones
AU623262B2 (en) Hydroxypropylamines
AU6673290A (en) Dipyridodiazepines
AU631622B2 (en) Snow-vehicle
AU6215190A (en) Shampoo composition
AU6111390A (en) Pesticidal formulations
AU623780B2 (en) Chromanderivate
AU6188990A (en) Self-polymerizable phenylquinoxalines
AU5870090A (en) Topical formulations
AU5316890A (en) Composition
AU5782590A (en) Thioxotetrazolines
AU5336690A (en) Leg-guard
AU6839190A (en) Triazolylsulfonamides
AU6627590A (en) Doll-container
AU5400390A (en) Substituted 1-phenylnaphthalenes
AU2431388A (en) Somototropin formulations
AU627847B2 (en) Pesticidal formulations
AU6268590A (en) Aminophosphinates
AU5915590A (en) Certain glyoxyl-cyclohexendiones
AU4944090A (en) Cryoelectrosynthesis
AU6217090A (en) Substituted amino-pyridines
AU623554B2 (en) Substituted sulphonylamidinohydrazones
AU5680990A (en) Composition